SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-119932
Filing Date
2018-04-17
Accepted
2018-04-17 17:16:33
Documents
4
Period of Report
2018-05-24
Effectiveness Date
2018-04-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d558293ddef14a.htm DEF 14A 480016
2 GRAPHIC g558293g0417080205839.jpg GRAPHIC 7178
3 GRAPHIC g558293g71g37.jpg GRAPHIC 3773
4 GRAPHIC g558293sp3.jpg GRAPHIC 1599
  Complete submission text file 0001193125-18-119932.txt   499047
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33057 | Film No.: 18759707
SIC: 2834 Pharmaceutical Preparations